AU7104294A - Method of detecting compounds utilizing genetically modified lambdoid bacteriophage - Google Patents

Method of detecting compounds utilizing genetically modified lambdoid bacteriophage

Info

Publication number
AU7104294A
AU7104294A AU71042/94A AU7104294A AU7104294A AU 7104294 A AU7104294 A AU 7104294A AU 71042/94 A AU71042/94 A AU 71042/94A AU 7104294 A AU7104294 A AU 7104294A AU 7104294 A AU7104294 A AU 7104294A
Authority
AU
Australia
Prior art keywords
genetically modified
detecting compounds
compounds utilizing
lambdoid bacteriophage
utilizing genetically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71042/94A
Inventor
Roberto Crea
Edmund C. C Lin
Bryan L Ray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symbiotech Inc
Original Assignee
Symbiotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbiotech Inc filed Critical Symbiotech Inc
Publication of AU7104294A publication Critical patent/AU7104294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU71042/94A 1994-06-10 1994-06-10 Method of detecting compounds utilizing genetically modified lambdoid bacteriophage Abandoned AU7104294A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/006543 WO1995034683A1 (en) 1994-06-10 1994-06-10 Method of detecting compounds utilizing genetically modified lambdoid bacteriophage

Publications (1)

Publication Number Publication Date
AU7104294A true AU7104294A (en) 1996-01-05

Family

ID=22242658

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71042/94A Abandoned AU7104294A (en) 1994-06-10 1994-06-10 Method of detecting compounds utilizing genetically modified lambdoid bacteriophage

Country Status (3)

Country Link
EP (1) EP0760012A4 (en)
AU (1) AU7104294A (en)
WO (1) WO1995034683A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750373A (en) * 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
EP1100890A2 (en) 1998-07-27 2001-05-23 Genentech, Inc. Improved transformation efficiency in phage display through modification of a coat protein
JP2003502304A (en) 1999-06-14 2003-01-21 ジェネンテック・インコーポレーテッド Structured peptide scaffolds for displaying turn libraries on phage
US6914123B2 (en) 2001-04-17 2005-07-05 Genentech, Inc. Hairpin peptides with a novel structural motif and methods relating thereto
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
EP2000545B1 (en) 2001-06-20 2011-08-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of lung tumor
KR101008758B1 (en) 2001-09-18 2011-01-14 제넨테크, 인크. Compositions and Methods for the Diagnosis and Treatment of Tumor
KR100623128B1 (en) 2002-01-02 2006-09-14 제넨테크, 인크. Compositions and Methods for the Diagnosis and Treatment of Tumor
MXPA04010092A (en) 2002-04-16 2004-12-13 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor.
SI2784084T2 (en) 2003-07-08 2024-02-29 Novartis Pharma Ag Antagonist antibodies to IL-17A/F heterologous polypeptides
US7329725B1 (en) 2003-10-29 2008-02-12 Nastech Pharmaceutical Company Inc. Phage displayed Trp cage ligands
SI2161283T1 (en) 2003-11-17 2014-10-30 Genentech, Inc. Compositions comprising antibodies against CD79b conjugated to a growth inhibitory agent or cytotoxic agent and methods for the treatment of tumor of hematopoietic origin
CA2597325A1 (en) 2005-03-10 2006-09-21 Genentech, Inc. Methods and compositions for modulating vascular integrity
EP2007428A2 (en) 2006-04-05 2008-12-31 Genentech, Inc. Method for using boc/cdo to modulate hedgehog signaling
EP2057465A4 (en) 2006-08-09 2010-04-21 Homestead Clinical Corp Organ-specific proteins and methods of their use
JPWO2008032833A1 (en) 2006-09-14 2010-01-28 株式会社医学生物学研究所 Antibody with enhanced ADCC activity and method for producing the same
WO2008103962A2 (en) 2007-02-22 2008-08-28 Genentech, Inc. Methods for detecting inflammatory bowel disease
US8575314B2 (en) 2008-06-20 2013-11-05 National University Corporation Okayama University Antibody against oxidized LDL/β2GPI complex and use of the same
US9182406B2 (en) 2008-08-04 2015-11-10 Biodesy, Inc. Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
CN107011415A (en) 2008-10-20 2017-08-04 光州科学技术院 Bipodal peptide binder
US9885711B2 (en) 2009-09-25 2018-02-06 Xoma Technology Ltd. Screening methods
RU2539772C2 (en) 2009-10-22 2015-01-27 Дженентек, Инк. Methods and compositions for hepsin modulation of macrophage-stimulating protein
MX2012006072A (en) 2009-11-30 2012-07-23 Genentech Inc Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 ).
AU2011221226A1 (en) 2010-02-23 2012-08-16 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CN107090045A (en) 2010-05-03 2017-08-25 霍夫曼-拉罗奇有限公司 Composition and method for tumor diagnosis and therapy
WO2012129347A1 (en) 2011-03-21 2012-09-27 Biodesy, Llc Classification of kinase inhibitors using nonlinear optical techniques
CN103930781A (en) 2011-09-15 2014-07-16 霍夫曼-拉罗奇有限公司 Methods of promoting differentiation
WO2013056148A2 (en) 2011-10-15 2013-04-18 Genentech, Inc. Methods of using scd1 antagonists
RU2014133547A (en) 2012-01-18 2016-03-10 Дженентек, Инк. WAYS OF APPLICATION OF FGF19 MODULATORS
WO2013162654A1 (en) 2012-04-25 2013-10-31 Biodesy, Llc Methods for detecting allosteric modulators of proteins
JP6545959B2 (en) 2012-02-11 2019-07-17 ジェネンテック， インコーポレイテッド R-Spondin rearrangement and method of using the same
CN104254541A (en) 2012-03-16 2014-12-31 弗·哈夫曼-拉罗切有限公司 Engineered conformationally-stabilized proteins
RU2014141018A (en) 2012-03-16 2016-05-10 Ф. Хоффманн-Ля Рош Аг METHODS OF TREATING MELANOMA WITH CANCER INHIBITORS
US9139863B2 (en) 2012-03-16 2015-09-22 Genentech, Inc. Engineered conformationally-stabilized proteins
WO2013170191A1 (en) 2012-05-11 2013-11-14 Genentech, Inc. Methods of using antagonists of nad biosynthesis from nicotinamide
CA2905798C (en) 2013-03-15 2023-01-24 Genentech, Inc. Biomarkers and methods of treating pd-1 and pd-l1 related conditions
WO2015116902A1 (en) 2014-01-31 2015-08-06 Genentech, Inc. G-protein coupled receptors in hedgehog signaling
JP2017524371A (en) 2014-05-23 2017-08-31 ジェネンテック， インコーポレイテッド MIT biomarkers and methods of use
WO2015196070A1 (en) 2014-06-20 2015-12-23 Genentech, Inc. Chagasin-based scaffold compositions, methods, and uses
EP3237906B8 (en) 2014-12-23 2020-10-28 Bluelight Therapeutics, Inc. Attachment of proteins to interfaces for use in nonlinear optical detection
KR102668727B1 (en) 2015-04-24 2024-05-28 제넨테크, 인크. Multispecific antigen-binding protein
JP2019534858A (en) 2016-09-09 2019-12-05 ジェネンテック， インコーポレイテッド Selective peptide inhibitor of FRIZZLED
WO2018152496A1 (en) 2017-02-17 2018-08-23 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Compositions and methods for the diagnosis and treatment of zika virus infection
WO2018200742A1 (en) 2017-04-25 2018-11-01 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
EP3655430A1 (en) 2017-07-19 2020-05-27 The U.S.A. as represented by the Secretary, Department of Health and Human Services Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
KR20220005568A (en) 2019-05-09 2022-01-13 제넨테크, 인크. Methods for making antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1303802A (en) * 1969-01-16 1973-01-24
DE3852304T3 (en) * 1987-03-02 1999-07-01 Enzon Lab Inc Organism as carrier for "Single Chain Antibody Domain (SCAD)".

Also Published As

Publication number Publication date
EP0760012A4 (en) 1997-07-02
EP0760012A1 (en) 1997-03-05
WO1995034683A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
AU7104294A (en) Method of detecting compounds utilizing genetically modified lambdoid bacteriophage
PL311736A1 (en) Derivatives of 1h-imidazoles
AU6107996A (en) Joining method
AU8254691A (en) Method of deepwater pipelay
AU3135097A (en) Methods of detection utilizing modified bacteriophage
AU2496197A (en) Method for the detection of creatinine
AU2372895A (en) Method of detecting ligand interactions
AU5194798A (en) Process for the preparation of radiopharmaceuticals
ZA981885B (en) Method for the preparation of alpha-bromo-lactam derivatives
AU2114295A (en) Manipulator-arm for auxiliary-tool for the joining of drillpipe
EP0691828A4 (en) Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
AU1857695A (en) Method for friction joining
IL108595A0 (en) Novel derivatives of tetramethylcyclopropane
AU7506896A (en) Method for the simultaneous detection of polygenes
AU3466795A (en) Improved method of manufacturing composites
PL310620A1 (en) Method of obtaining condenset carbapenemic derivatives
PL303946A1 (en) Method of obtaining indoles
HUT73184A (en) Method of manufacturing the cycloheptimidazole derivatives
AU5038998A (en) Method for the synthesis of deoxypyridinoline
GB9707251D0 (en) Novel method and compounds
AU3400695A (en) Method of drying of sludge
GB9825065D0 (en) Method of expolosives detection
EP0738707A3 (en) Dianilinoglutacondialdehyde compound and process for the preparation thereof
PL302380A1 (en) Novel derivative of pyrimidobenzodiazepin
AUPO207796A0 (en) Method of detection